David F. Novack - 10 Feb 2022 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role: President & COO
Signature: David Novack, /s/ Trevor Dutcher, Attorney-in-Fact
Issuer symbol: DVAX
Transactions as of: 10 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 14 Feb 2022, 20:16:54 UTC
Previous filing: 02 Nov 2021
Next filing: 04 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DVAX	Common Stock	Options Exercise		+52,500	+119%		96,566	10 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DVAX	Restricted Stock Unit	Options Exercise		+52,500			0	10 Feb 2022	Common Stock	52,500		Direct	F1
transaction	DVAX	Stock Option (Right to Buy)	Award	$0	+150,000		$0.000000	150,000	10 Feb 2022	Common Stock	150,000	$12.74	Direct	F2
transaction	DVAX	Restricted Stock Unit	Award		+26,500			26,500	10 Feb 2022	Common Stock	26,500		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The RSUs vest upon Issuer's common stock achieving a specified price per share for a specified period.
F2	This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 10, 2022, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
F3	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022